_6e98296023b34dfabc133638c1ef5d32-620x480.jpg "Advances in organoids could transform the treatment of spinal cord and peripheral nerve injuries")
Carlsbad, California, July 9, 2025 (Globe Newswire) – Aurora Spine Corporation (“Aurora Spine” or “Company”) (TSXV: ASG) (OTCQB: ASAPF), an innovative and innovative innovative pain management system, an innovative fusion management system, it has the initial surgeries that use Aurora Spine ‘ Product, the Aero ™ Leadra ™ leads. The minimally invasive procedures used by the Aero were carried out by two different surgeons, an ortho surgeon and an interventionist. The initial surgeries carried out were procedures carried out in the lumbar part of the spine.
“We are very happy to announce our new product: the aerodynamic lumbar fusion system has begun to be used by surgeons and implemented in patients,” said Trent Northcutt, president and CEO of Aurora Spine. “The initial feedback has been extremely positive, and we hope that additional surgeons will begin to use the aer involved in patients.
The Lumbar Aero Mis Lumbar System is a novel and pending patent device designed to provide a minimally invasive solution for patients suffering from pain or instability related to facial joint. Cleaned for use of spinal levels C2 A S1 (inclusive), the system can be used as an independent facet fusion procedure or as a complement of larger spinal fusion surgeries.
Designed for previous use in the continuum of care, Aero is ideal for patients who experience mechanical back pain, lower instability or articular degenerative disease that have not responded to conservative therapies. The system incorporates intuitive instrumentation and implant technology designed to promote bone fusion while minimizing the interruption of soft tissues, aligning with Aurora Spine’s commitment to advance in friendly innovations for the patient and friendly with surgeons.
About Aurora’s column
Aurora Spine focuses on bringing new solutions to the market of spinal implants through a series of patented, minimally invasive and regenerative technologies. The company undertakes to improve surgical results through innovation, efficiency and patient -centered design.
For more information, visit: www.aurora-spine.com
Declarations with advance
This press release contains prospective information that implies known risks and uncertainties and unknown substantial, many of which are beyond the control of Aurora Spine. Prospective statements include, among others, statements about the expected use and success of the company’s products, including the Aer Facet Fusion system. The real results may differ materially. See the final prospect and public presentations of Aurora Spine to obtain additional information on risks and uncertainties.
These prospective statements speak only as of the date of this version. Aurora’s backbone has no obligation to review or update them to reflect future events or circumstances.
Contacts:
Aurora Spine Corporation
Trent northcutt
President and Executive Director
(760) 424-2004
Chad Clouse
Financial Director
(760) 424-2004
www.aurora-spine.com
Inverter contact:
Adam Lowensteiner
Lytham Partners
(646) 829-9702
Email: asapf@lythampartners.com
